Roche Holding AG News and Biotechnology & Pharmaceutical Industry Updates

391.5
1.60
0.41 %
Daily range
Weekly range
  • Sergey Shendetskyi
  • 19.10.2026
Hansoh Pharmaceutical, Roche strike antibody-drug conjugate deal worth over $15 billion
China's Hansoh Pharmaceutical is expanding its oncology collaboration with Roche through a licensing partnership that could exceed $15 billion in total value. The agreement gives Hansoh ...
  • Dmytro Kharkov
  • 13.10.2026
Roche licenses obesity drug candidate from China’s Rona Therapeutics in deal worth up to $1.16 billion
Roche is expanding its push into the fast-growing obesity treatment market with a licensing agreement for an experimental drug candidate from China-based Rona Therapeutics. The deal gives the ...
  • Jainam Mehta
  • 05.10.2026
Alector shares jump as Roche licenses Parkinson's therapy in $1.27 billion deal
Biotechnology dealmaking is continuing in neurodegenerative disease as Alector secures a licensing agreement for its experimental Parkinson's treatment with Roche. The pact includes $100 million ...